What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Searched for "active".
Recall
|
Medicines
|
05/07/2018
The marketing authorization holder has informed its supplied customers in a letter dated July 4, 2018, that the active ingredient valsartan may contain a genotoxic impurity with carcinogenic potential.Based on this information from the active…
Recall
|
Medicines
|
05/07/2018
The marketing authorization holder has informed its supplied customers in a letter dated 04.07.2018 that the active ingredient Valsartan may contain a genotoxic impurity with carcinogenic potential. Based on this information from the active…
Recall
|
Medicines
|
05/07/2018
The marketing authorization holder has informed its supplied customers in a letter dated 05.07.2018 that an impurity was detected during the review at the active ingredient level. This impurity is classified as potentially carcinogenic. Therefore, a…
Recall
|
Medicines
|
05/07/2018
In a letter dated July 5, 2018, the marketing authorization holder informed its customers that the active ingredient manufacturer had detected the production-related impurity N-nitrosodimethylamine (NDMA) in the active ingredient valsartan.…
Recall
|
Medicines
|
05/07/2018
The marketing authorization holder has informed its customers in a letter dated December 31, 2009, that a production-related impurity has arisen at the active ingredient manufacturer during a synthesis step. This impurity is N-nitrosodimethylamine…
Recall
|
Medicines
|
05/07/2018
The marketing authorization holder informed its supplied customers in a letter dated December 31, 2009, that a production-related impurity occurred during a synthesis step at the active ingredient manufacturer's. The impurity is…
Recall
|
Medicines
|
25/05/2018
The marketing authorization holder has informed its supplied customers in a letter dated May 25, 2018, that a blister strip of another product from the same active ingredient group has been discovered in batch W28311 in a single package. As a…
Enforcement
|
24/04/2018
Shopping on the internet offers, in addition to seemingly unlimited choices and convenient time savings, one thing above all: anonymity. In particular, "sensitive" goods, such as sexual enhancers or lifestyle products, are often purchased via Internet retailers to avoid supposedly embarrassing moments at the doctor's or pharmacy. However, this means that one's own health is often (unknowingly) put at an incalculable risk.
messages in brief
|
17/04/2018
World Hemophilia Day 2018 Hemophilia is a congenital, lifelong increased bleeding tendency in which a deficiency or complete absence of certain blood components (clotting factors) leads to a disturbance of normal hemostasis. Approximately 850,…
11/04/2018
ACTIVITIES AND LOCATIONS INSTITUTES Assessment & Analytics Dr. Gerhard Beck Traisengasse 5 A-1200 Vienna Phone: +43 50 555-36300 gerhard.beck@ages.at OMCL Biological Medicines DI Heidemarie Schindl Po [...] surveillance, inspection eg. of manufacturers and clinical trials. When carrying out sovereign activities, the employees of AGES MEA are acting on behalf of the Federal Office for Safety in Health Care [...] used by AGES MEA implements the requirements of ISO 9001, as well as ISO 17025 for OMCL testing activities. Values of AGES MEA • WE ARE RESPONSIBLE We are committed to working in the interest of the health
Referenced at: